Related Experiment Video

Updated: Jun 19, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
06:31

Transuterine Fetal Tracheal Occlusion Model in Mice

Published on: February 5, 2021

Management of prenatally diagnosed congenital diaphragmatic hernia

Holly L Hedrick1

  • 1University of Pennsylvania, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. Hedrick@email.chop.edu

Seminars in Fetal & Neonatal Medicine
|November 4, 2009
PubMed

Insights

Congenital diaphragmatic hernia (CDH) is a serious birth defect impacting lung development. While neonatal care improves survival, severe cases still face high mortality, necessitating better prenatal prediction and validated treatments.

Area of Science:

  • Neonatalogy
  • Pediatric Surgery
  • Congenital Anomalies

Background:

  • Congenital diaphragmatic hernia (CDH) presents with variable severity, linked to pulmonary hypoplasia and hypertension.
  • Despite advances in neonatal care, severe CDH cases have high mortality and morbidity.
  • Liver position is a key prenatal predictor for left-sided CDH outcomes.

Purpose of the Study:

  • To highlight the need for improved prenatal predictive parameters in CDH.
  • To discuss the current status of prenatal interventions for CDH.
  • To emphasize the importance of long-term follow-up for CDH survivors.

Main Methods:

  • Review of existing literature on congenital diaphragmatic hernia.
  • Analysis of prenatal predictors and outcomes in CDH.
  • Evaluation of randomized trials and non-randomized reports on prenatal interventions.

Main Results:

  • Current prenatal predictive parameters require enhancement for standardization.
  • Randomized trials have not yet demonstrated benefit for prenatal interventions in CDH.
  • Non-randomized studies show promise for techniques like balloon tracheal occlusion, but require further validation.

Conclusions:

  • Development of precise prenatal predictive tools is crucial for standardizing CDH research and clinical trials.
  • Prenatal therapies for CDH require rigorous prospective randomized trials to confirm efficacy before widespread adoption.
  • Increased survival rates necessitate comprehensive long-term follow-up and support systems for CDH survivors.

More Related Videos

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs05:40

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Published on: December 22, 2023

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History: